Concepedia

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes

Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, Georges Dagher, Anthony J. Filiano, Jacques Galipeau, Mauro Krampera, Lena Krieger, Manoj M. Lalu, Jan A. Nolta,

Cytotherapy · 2023 · 22 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al. · Cytotherapy · 2006 · 17.4K citations

, , +12

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet · 2016 · 1K citations

, , +8

Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature

Sowmya Viswanathan, Yufang Shi, Jacques Galipeau et al. · Cytotherapy · 2019 · 777 citations

, , +12

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Jacques Galipeau, Mauro Krampera, John Barrett et al. · Cytotherapy · 2015 · 491 citations · Full text

, , +10

MSC-Based Product Characterization for Clinical Trials: An FDA Perspective

Michael Mendicino, Alexander M. Bailey, Keith Wonnacott et al. · Cell stem cell · 2014 · 475 citations · Full text

, , +6